GoodRx Holdings, Inc.

NasdaqGS:GDRX Stok Raporu

Piyasa değeri: US$2.7b

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

GoodRx Holdings Yönetim

Yönetim kriter kontrolleri 2/4

GoodRx Holdings' CEO'su Scott Wagner, Apr2023 tarihinde atandı, in görev süresi 1.5 yıldır. in toplam yıllık tazminatı $ 10.14M olup, şirket hissesi ve opsiyonları dahil olmak üzere 5% maaş ve 95% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.097% ine doğrudan sahiptir ve bu hisseler $ 2.55M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 2.5 yıl ve 7.2 yıldır.

Anahtar bilgiler

Scott Wagner

İcra Kurulu Başkanı

US$10.1m

Toplam tazminat

CEO maaş yüzdesi5.0%
CEO görev süresi1.5yrs
CEO sahipliği0.1%
Yönetim ortalama görev süresi2.5yrs
Yönetim Kurulu ortalama görev süresi7.2yrs

Son yönetim güncellemeleri

Recent updates

GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital Not Reflecting Well On The Business

Sep 22
GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital Not Reflecting Well On The Business

GoodRx Q2 Earnings Preview

Jul 31

GoodRx Holdings (NASDAQ:GDRX) Could Easily Take On More Debt

Jul 12
GoodRx Holdings (NASDAQ:GDRX) Could Easily Take On More Debt

GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 30% Price Boost Is Out Of Tune With Revenues

Jun 09
GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 30% Price Boost Is Out Of Tune With Revenues

Returns On Capital At GoodRx Holdings (NASDAQ:GDRX) Paint A Concerning Picture

Jun 06
Returns On Capital At GoodRx Holdings (NASDAQ:GDRX) Paint A Concerning Picture

GoodRx: Encouraging Profit Stabilization (Rating Upgrade)

May 28

GoodRx Holdings: Large TAM Continues To Support Growth

Mar 20

GoodRx Holdings, Inc. (NASDAQ:GDRX) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Mar 07
GoodRx Holdings, Inc. (NASDAQ:GDRX) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Is GoodRx Holdings, Inc. (NASDAQ:GDRX) Trading At A 24% Discount?

Mar 01
Is GoodRx Holdings, Inc. (NASDAQ:GDRX) Trading At A 24% Discount?

GoodRx Holdings (NASDAQ:GDRX) Has A Rock Solid Balance Sheet

Feb 12
GoodRx Holdings (NASDAQ:GDRX) Has A Rock Solid Balance Sheet

GoodRx: Cost Saving Is A Strong Value Proposition To Consumers

Jan 23

GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

Jan 22
GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

GoodRx Stock Spikes After Receiving A Strong Dose Of Performance

Jan 11

What Is GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Share Price Doing?

Dec 02
What Is GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Share Price Doing?

GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

Sep 12
GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

An Intrinsic Calculation For GoodRx Holdings, Inc. (NASDAQ:GDRX) Suggests It's 41% Undervalued

Jul 14
An Intrinsic Calculation For GoodRx Holdings, Inc. (NASDAQ:GDRX) Suggests It's 41% Undervalued

GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital Not Reflecting Well On The Business

May 27
GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital Not Reflecting Well On The Business

Some Confidence Is Lacking In GoodRx Holdings, Inc. (NASDAQ:GDRX) As Shares Slide 27%

May 05
Some Confidence Is Lacking In GoodRx Holdings, Inc. (NASDAQ:GDRX) As Shares Slide 27%

Investors Give GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares A 27% Hiding

May 05
Investors Give GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares A 27% Hiding

Is There An Opportunity With GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 45% Undervaluation?

Mar 23
Is There An Opportunity With GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 45% Undervaluation?

GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

Feb 07
GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

GoodRx Holdings (NASDAQ:GDRX) Could Be Struggling To Allocate Capital

Nov 02
GoodRx Holdings (NASDAQ:GDRX) Could Be Struggling To Allocate Capital

GoodRx laying off 140 employees, 16% of workforce

Aug 31

GoodRx: Trending Positive, But Not A Buy Yet

Aug 25

CEO Tazminat Analizi

Scott Wagner'un ücretlendirmesi GoodRx Holdings'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-US$59m

Mar 31 2024n/an/a

-US$7m

Dec 31 2023US$10mUS$512k

-US$9m

Tazminat ve Piyasa: Scott 'nin toplam tazminatı ($USD 10.14M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 6.79M ).

Tazminat ve Kazançlar: Scott şirketinin tazminatını şirket performansıyla karşılaştırmak için yeterli veri yok.


CEO

Scott Wagner (53 yo)

1.5yrs

Görev süresi

US$10,144,526

Tazminat

Mr. Scott W. Wagner serves as Interim Chief Executive Officer at GoodRx Holdings, Inc. since April 25, 2023 and serves as its Principal Operating Officer since February 15, 2024. He serves as Head of Strat...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Trevor Bezdek
Co-founder & Chairman of the Board13.1yrsUS$811.53k1.42%
$ 38.2m
Scott Wagner
Interim CEO & Principal Operating Officer1.5yrsUS$10.14m0.097%
$ 2.6m
Douglas Hirsch
Co-founder13.1yrsUS$784.86k1.42%
$ 38.2m
Karsten Voermann
Chief Financial Officer4.6yrsUS$902.24k0.072%
$ 1.9m
Romin Nabiey
Chief Accounting Officer2.5yrsUS$2.58m0.019%
$ 514.9k
Bansi Nagji
President of Healthcare4.3yrsUS$4.91m0.065%
$ 1.8m
Mike Walsh
President & Executive VP of Prescription Marketplaceless than a yearVeri yokVeri yok
Nitin Shingate
Chief Technology Officer1.8yrsVeri yokVeri yok
Aubrey Reynolds
Director of Investor Relationsno dataVeri yokVeri yok
Gracye Cheng
General Counsel & Secretaryno dataVeri yokVeri yok
Andrew Slutsky
Chief Marketing Officer1.3yrsUS$864.80k0%
$ 0
Vina Leite
Chief People Officer2.4yrsVeri yokVeri yok

2.5yrs

Ortalama Görev Süresi

53yo

Ortalama Yaş

Deneyimli Yönetim: GDRX 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.5 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Trevor Bezdek
Co-founder & Chairman of the Board13.1yrsUS$811.53k1.42%
$ 38.2m
Douglas Hirsch
Co-founder13.1yrsUS$784.86k1.42%
$ 38.2m
Gregory Mondre
Independent Director6yrsVeri yokVeri yok
Dipanjan Deb
Independent Director9yrsVeri yokVeri yok
Ian T. Clark
Directorless than a yearVeri yokVeri yok
Agnes Rey-Giraud
Independent Director8.3yrsUS$269.53k0.079%
$ 2.1m
Julie M. Bradley
Independent Director4.2yrsUS$272.53k0.025%
$ 675.3k
Christopher Adams
Independent Director9yrsVeri yokVeri yok
Simon Patterson
Directorless than a yearVeri yokVeri yok
Kelly Kennedy
Independent Directorless than a yearUS$448.63kVeri yok

7.2yrs

Ortalama Görev Süresi

54yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: GDRX 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 7.2 yıldır).